ORAL INHIBITOR OF TISSUE TRANSGLUTAMINASE PREVENTS MUCOSAL DAMAGE IN CELIAC PATIENTS UNDERGOING GLUTEN CHALLENGE
Jorma Isola 1
Tina Friesing-Sosnik 2
Yurdagül Zopf 3
Mika Scheinin 4
valerie byrnes 5
Detlef Schuppan
Helga Török 6
1 Tampere University, Tampere, Finland
2 University Medical Center, Research Center for Immune Therapy, Mainz, Germany
3 Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
4 Clinical Research Services Turku - CRST Oy, Turku, Finland
5 University College Hospital Galway, Galway, Ireland
6 University Hospital, LMU Munich, Munich, Germany
Topic
IBD
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]